My clinical pharmacy research interests include: anemia and bone disease management in the chronic kidney disease (CKD) population, specifically investigating newer agents being utilized to treat these disease states and protocol driven practices. Another area of my pharmacy practice research in nephrology is vascular access. Areas of research include access related infections, specifically understanding infection rates, organisms involved and locking devices for catheters and their clinical outcomes. Furthermore, dialysis modalities have evolved and the pharmacokinetics of drugs has also changed. Therefore much of my research has focused on drug clearance with these newer modalities. Lastly, another area of my research is pharmacy practice research. Here we have investigated different pharmacy services for the dialysis patient and outcomes. I have been the lead investigator on a number of research projects in these areas. Please refer to list of publications for the scope of my clinical research.
A systematic review of direct oral anticoagulant use in chronic kidney disease and dialysis patients with atrial fibrillation.
Nephrol Dial Transplant. 2018 Mar 02;:
Br J Dermatol. 2018 Jan 08;:
CANNT J. 2014 Oct-Dec;24(4):19-22
CANNT J. 2014 Jul-Sep;24(3):20-2
CANNT J. 2017 Jan-Mar;27(1):19-22
J Eur Acad Dermatol Venereol. 2017 Nov 08;:
Warfarin Use in Hemodialysis Patients With Atrial Fibrillation: A Systematic Review of Stroke and Bleeding Outcomes.
Can J Kidney Health Dis. 2017;4:2054358117735532
Targeted Deprescribing in an Outpatient Hemodialysis Unit: A Quality Improvement Study to Decrease Polypharmacy.
Am J Kidney Dis. 2017 Apr 14;:
PDGFRa amplification in multiple skin lesions of undifferentiated pleomorphic sarcoma (UPS): a clue for intimal sarcoma metastases.
J Cutan Pathol. 2017 Jan 20;:
Oncogene. 2017 Jan 16;: